Spectral AI Inc. (NASDAQ:MDAI) revealed Monday the performance results of its DeepView System in connection with the completion of its Burn Validation Study. Spectral AI, which focuses on medical ...
Spectral AI's DeepView System excels over physicians in identifying non-healing burn tissue, aiming for FDA clearance by mid-2025. Spectral AI has announced positive results from its Burn Validation ...
DALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
DALLAS, May 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView ® System, which uses multi-spectral imaging ...
DALLAS, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster ...
DALLAS, July 08, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
The First Reader Study of Burn Wounds with Predictive Artificial Intelligence Analysis – Dr. Jeffrey Carter, M.D., Louisiana State University Health Science Center Artificial Intelligence-Enhanced ...